Skip to main content


Nuclear Medicine and Molecular Imaging

Nuclear Medicine and Molecular Imaging OnlineFirst articles

23.09.2021 | Interesting image

Multifocal Meningiomas Mimicking Metastasis on 18F-Fluciclovine PET/CT

A 65-year-old male patient with a past medical history of prostate adenocarcinoma presented with biochemical recurrence (prostate-specific antigen level of 5.91 mg/L). 18F-FACBC PET/CT was acquired to evaluate the disease recurrence and …

18.09.2021 | Original Article

Patient-Specific Dosimetry in Radioligand Therapy (RLT) for Metastatic Prostate Cancer Using 177Lu-DKFZ-PSMA-617

Prostate cancer (PCa) is the most common type of cancer in men worldwide [ 1 , 2 ]. Despite several treatment options such as chemotherapy, hormone, and radiation therapy, more than 250,000 men are still dying from prostate cancer each year around …

10.09.2021 | Case Report

Radioguided Surgery in Insulinoma Using 68Ga Labeled Exendin-4: a Case Report

Laparoscopic resection of tumor is often performed for benign and small insulinomas, or for those located in the body or tail of the pancreas. The precise preoperative and intraoperative localization of the insulinoma is critical to minimize the …

31.08.2021 | Review

KSNM60 in Clinical Nuclear Oncology

Since the foundation of the Korean Society of Nuclear Medicine in 1961, clinical nuclear oncology has been a major part of clinical nuclear medicine in Korea. There are several important events for the development of clinical nuclear oncology in …

23.08.2021 | Review

KSNM60 in Non-thyroidal Radionuclide Therapy: Leaping into the Future

This year, the Korean Society of Nuclear Medicine (KSNM) is celebrating its 60th anniversary. Treatment, as well as diagnosis, has played a very important role in the development of nuclear medicine. Since I-131 was used for thyroid therapy in …

Aktuelle Ausgaben

Über diese Zeitschrift

Nuclear Medicine and Molecular Imaging (Nucl Med Mol Imaging) publishes papers on nuclear medicine and a wide range of related sciences including radiochemistry, radiopharmacy, dosimetry and pharmacokinetics/pharmacodynamics of radiopharmaceuticals, nuclear and molecular imaging analysis, nuclear and molecular imaging instrumentation, radiation biology and radionuclide therapy. The journal also presents original works relating to molecular imaging research, such as the development of molecular imaging probes, reporter imaging assays, imaging cell trafficking, imaging endo(exo)genous gene expression, and imaging signal transduction. Content includes original articles, reviews, case reports, editorials, interesting images, and letters to the editor. Nucl Med Mol Imaging is an official journal of the Korean Society of Nuclear Medicine. KSNM members read this journal plus the official journals of the EANM and the Japanese Nuclear Medicine Society online for free.

Ethical Standards

Manuscripts submitted for publication must contain a statement to the effect that all human and animal studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted. The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or failure to fulfill the above-mentioned requirementsAll contributions should also follow the good publication practice guidelines for medical journals, which were established by Korean Association of Medical Journal Editors (

Conflict of Interest

When an author or the institution of the author has a relationship, financial or otherwise, with individuals or organizations that could influence the author’s work inappropriately, a conflict of interest may exist. Examples of potential conflicts of interest may include but are not limited to academic, personal, or political relationships; employment; consultancies or honoraria; and finical connections such as stock ownership and funding. Although an author may not feel that there are conflicts, disclosure of relationships and interests that could be viewed by others as conflicts of interest affords a more transparent and prudent process. All authors must disclose any actual or potential conflict of interest. The Journal may publish such disclosures if judged to be important to readers.

Weitere Informationen